Infusion of MSC
CeTMAd-VIH-2014
Phase 2 small_molecule completed
Quick answer
Infusion of MSC for Discordant Immunological Response in HIV Infected Subjects is a Phase 2 program (small_molecule) at Design Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Design Therapeutics
- Indication
- Discordant Immunological Response in HIV Infected Subjects
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed